Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-09-08

Clinical Trial Update: IDegLira HIGH Trial [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial updating on IDegLira HIGH showed completed status with results posted in 2023, involving diabetes mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IDegLira (insulin degludec/liraglutide)

Snippet

Sponsor: Emory University | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2023-09-08